In 2017 Moreno-Navarrete et al. reported a significant increase of FLVCR1 expression in both the visceral and the subcutaneous adipose tissue of patients affected by type 2 diabetes (T2D) as compared to non-diabetic subjects [75]. The gene discussed is FLVCR1; the disease is type 2 diabetes mellitus.